Defining Robust Predictors of Chemotherapy Related Cardiotoxicity

Status Recruiting

Clinical Trial Summary

Observational prospective cohort study designed for patients with gastrointestinal cancers receiving a fluoropyrimidine based chemotherapy regimen.

Clinical Trial Description

All enrolled participants will undergo baseline cardiovascular risk assessment (using QRISK3 and SCORE 2 risk calculators), cardiac, oncological and medication history. All participants will have serial cardiac symptom assessment, 12 lead ECG and cardiac biomarker assessments(high sensitivity troponin T and NT pro BNP) at baseline, on completion of the first cycle of treatment and post completion of treatment. Participants will be followed up for the development of cardiotoxicity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05159479
Study type	Observational
Source	University College, London
Contact	Aderonke Abiodun
Phone	07737138851
Email	aderonketemilade.abiodun@nhs.net
Status	Recruiting
Phase
Start date	October 13, 2021
Completion date	July 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05551052` - CRC Detection Reliable Assessment With Blood
Terminated	`NCT01624090` - Mithramycin for Lung, Esophagus, and Other Chest Cancers	Phase 2
Completed	`NCT05178095` - Artificial Intelligence in Colonic Polyp Detection	N/A
Recruiting	`NCT03602677` - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage	N/A
Not yet recruiting	`NCT05552729` - Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors	Phase 1/Phase 2
Recruiting	`NCT02871245` - Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery	N/A
Completed	`NCT04694521` - Outcomes of Side-to-end Versus End-to-end Colorectal Anastomosis in Non-emergent Sigmoid and Rectal Cancers: Randomized Controlled Clinical Trial	N/A
Not yet recruiting	`NCT02860429` - Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma	Phase 4
Completed	`NCT02454647` - Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients	N/A
Recruiting	`NCT02196935` - Los Angeles Prospective GI Biliary and EUS Series
Completed	`NCT00190801` - Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma	Phase 2
Completed	`NCT00289445` - Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)	Phase 1/Phase 2
Completed	`NCT04010227` - Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers	N/A
Recruiting	`NCT03330964` - Clinical Trial of Electroacupuncture Stimulation on Prevention and Treatment of Oxaliplatin Neurotoxicity	N/A
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Recruiting	`NCT05322486` - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed	`NCT03559543` - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma	Phase 2
Completed	`NCT03549494` - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction	Phase 2
Recruiting	`NCT02672774` - Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers	N/A
Completed	`NCT02444572` - Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®	Phase 4